CROs/Service Providers

PPD expands GMP laboratory in Ireland

Wednesday, January 21, 2015 12:59 PM

Pharmaceutical Product Development (PPD), a global CRO based in Wilmington, N.C., has expanded its good manufacturing practices (GMP) operations in Athlone, Ireland, by adding a new, state-of-the-art laboratory for cell-based assays to its existing portfolio of services at the facility. The new lab provides GMP bioassay testing with dedicated areas to support cell culture activities with multiple assay endpoint expertise.

More... »

Theorem Clinical Research

WCCT Global, NIAID to collaborate on influenza challenge research

Friday, January 16, 2015 12:26 PM

CRO WCCT Global, headquartered in Southern California, is collaborating with the National Institute of Allergy and Infectious Diseases (NIAID) for influenza challenge research. With the construction of WCCT Global's influenza challenge facility in Costa Mesa, Calif., the CRO has the capability to conduct virus challenge clinical trials in North America.

More... »

Quest Diagnostics

Cromsource supports Italian Cystic Fibrosis Society’s clinical research training initiative

Thursday, January 15, 2015 01:19 PM

Cromsource, an international CRO, is delivering several modules of a training course on clinical research best practice organized by the SIFC (Italian Cystic Fibrosis Society). The course commenced in December 2014 and will complete in February 2015.

More... »

Covance to vote on proposed acquisition by LabCorp Feb. 18

Tuesday, January 13, 2015 08:00 AM

CRO Covance has set a date for a special meeting of its stockholders to consider and vote on the previously announced proposed acquisition of Covance by Laboratory Corporation of America Holdings (LabCorp) and certain other related matters. The special meeting will be held Feb. 18, at 8 a.m., in Princeton, N.J.

More... »

Novella Clinical, Cardiovascular Research Foundation collaborate, provide clinical trial expertise

Monday, January 12, 2015 02:37 PM

Novella Clinical, a Quintiles company, and the Cardiovascular Research Foundation (CRF), an independent, academically focused nonprofit organization based in New York, have announced a preferred provider collaboration that will offer a set of clinical trial services to developers of cardiovascular drugs and devices.

More... »

AMRI to acquire Aptuit drug development, aseptic manufacturing businesses

Friday, January 9, 2015 02:01 PM

Albany Molecular Research (AMRI), a global contract research and manufacturing organization, has acquired the outstanding equity interests of Aptuit's Glasgow, U.K., business and has entered into a definitive agreement to acquire Aptuit's SSCI/West Lafayette, Ind., business, for a total of $60 million, expanding AMRI's drug product development and aseptic clinical manufacturing capabilities.

More... »

WuXi PharmaTech acquires NextCODE Health

Friday, January 9, 2015 01:58 PM

WuXi PharmaTech, an open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries with operations in China and the U.S., has acquired NextCODE Health, a genomic analysis and bioinformatics company with operations in the U.S. and Iceland, for $65 million in cash.

More... »

Clinical Network Services establishes U.S. operations

Thursday, January 8, 2015 12:57 PM

Clinical Network Services (CNS), an integrated product development company based in Australia, New Zealand and the U.K., providing planning, implementation and delivery of preclinical through phase II trials, has established an office in the U.S. CNS also has appointed Megan Hill business development manager in the U.S.

More... »

CRF Health gains private equity investment, new majority shareholder, to help fuel expansion

Thursday, January 8, 2015 12:52 PM

CRF Health, a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry, has announced a significant investment of funds managed and advised by Vitruvian Partners, a London-based private equity firm, subject only to customary regulatory approvals.

More... »

Certara’s Synchrogenix acquires ClinGenuity

Wednesday, January 7, 2015 12:57 PM

Synchrogenix, the regulatory and medical consultancy of Certara, a Princeton, N.J.-based global biosimulation technology-enabled drug development and drug safety consulting company, has acquired ClinGenuity, a Cincinnati-based artificial intelligence-assisted medical writing service. Their combined team now will include more than 200 regulatory and medical writers with experience in document development for the FDAEMA and other global regulatory organizations.

More... »


March 30

Icon, Carnegie Mellon partner to research ways to improve study patients' understanding of Informed Consent

Veeva launches OpenKey, partner program to unlock difficult access to, restrictions on customer reference data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs